ACCELERATE DIAGNOSTICS, INC

Profile

Company Names

ACCELERATE DIAGNOSTICS, INC
ACCELR8 TECHNOLOGY CORP

Addresses

3950 SOUTH COUNTRY CLUB ROAD, SUITE 470, TUCSON, AZ 85714

3950 S COUNTRY CLUB, #470, TUCSON, AZ 85714

3950 SOUTH COUNTRY CLUB, SUITE 470, TUCSON, AZ 85714

7000 NORTH BROADWAY, BUILDING 3-307, DENVER, CO 80221

7000 NORTH BROADWAY, BUILDING 3-307, DENVER, CO 80221

Phone Numbers

520-365-31 00
520-365-3100
303-863-8088

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER HEALTH CARE

Year Incorporated:

> 5 years ago

State Incorporated:

COLORADO

Total Amount Raised:

$74,515,845.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2022-03-24 
$4,000,000.00 
$4,000,000.00 
$0.00 
Equity 
7
2021-09-22 
$30,450,000.00 
$30,450,000.00 
$0.00 
Equity 
6
2020-12-24 
$1,550,000.00 
$1,550,000.00 
$0.00 
Equity 
5
2019-08-20 
$999,992.00 
$999,992.00 
$0.00 
Equity 
4
2014-05-19 
$19,499,609.00 
$19,499,609.00 
$0.00 
Equity 
3
2013-08-14 
$3,321,244.00 
INDEFINITE 
INDEFINITE 
Equity 
2
2012-06-26 
$14,420,000.00 
$14,420,000.00 
$0.00 
Equity 
1
2010-03-17 
$275,000.00 
$2,000,000.00 
$1,725,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
PETE 
 
BANTOCK 
EXECUTIVE OFFICER
ACCELERATE DIAGNOSTICS, INC
THOMAS 
D. 
BROWN 
DIRECTOR
CEPHEID   |  ACCELERATE DIAGNOSTICS, INC
WAYNE 
C. 
BURRIS 
DIRECTOR
ACCELERATE DIAGNOSTICS, INC
ROLAND 
 
DIGGELMANN 
DIRECTOR
ACCELERATE DIAGNOSTICS, INC   |  SONOVA HOLDING AG
LOUISE 
L. 
FRANCESCONI 
DIRECTOR
ACCELERATE DIAGNOSTICS, INC
THOMAS 
 
GEIMER 
DIRECTOR
ACCELR8 TECHNOLOGY CORP
THOMAS 
V. 
GEIMER 
DIRECTOR, EXECUTIVE OFFICER
ACCELR8 TECHNOLOGY CORP
CHARLES 
E. 
GERRETSON 
DIRECTOR
ACCELR8 TECHNOLOGY CORP
DAVID 
C. 
HOWSON 
EXECUTIVE OFFICER
ACCELR8 TECHNOLOGY CORP
ROMNEY 
 
HUMPHRIES 
EXECUTIVE OFFICER
ACCELERATE DIAGNOSTICS, INC
JOHN 
D. 
KUCERA 
DIRECTOR
ACCELR8 TECHNOLOGY CORP
HANY 
 
MASSARANY 
DIRECTOR
BIODESIX INC   |  ACCELERATE DIAGNOSTICS, INC
LAWRENCE 
 
MEHREN 
EXECUTIVE OFFICER, DIRECTOR
ACCELR8 TECHNOLOGY CORP   |  ACCELERATE DIAGNOSTICS, INC
MARK 
C. 
MILLER 
DIRECTOR
ACCELERATE DIAGNOSTICS, INC
JOHN 
 
PATIENCE 
DIRECTOR
BIODESIX INC   |  BIRCKENNBACH IV, LP   |  ACCELR8 TECHNOLOGY CORP   |  ACCELERATE DIAGNOSTICS, INC
JOHN 
J. 
PHILLIPS 
EXECUTIVE OFFICER, DIRECTOR
BARINGS CORE PROPERTY FUND LP   |  ACCELERATE DIAGNOSTICS, INC   |  CREF X MA REIT LLC   |  BIG FUND REIT LLC
RON 
 
PRICE 
EXECUTIVE OFFICER, DIRECTOR
TRANSILIO, INC.   |  SMARTSTORY TECHNOLOGIES, INC.   |  ACCELERATE DIAGNOSTICS, INC
STEVE 
 
REICHLING 
EXECUTIVE OFFICER
ACCELERATE DIAGNOSTICS, INC
JACK 
 
SCHULER 
DIRECTOR
BIODESIX INC   |  ACCELR8 TECHNOLOGY CORP   |  ACCELERATE DIAGNOSTICS, INC   |  MONTERIS BC HOLDINGS 3, LLC   |  ED BC HOLDINGS 3, LLC   |  MONTERIS BC HOLDINGS 4, LLC   |  MONTERIS BC HOLDINGS 5, LLC   |  BIRCHVIEW CAPITAL VF III, LLC   |  MONTERIS BC HOLDINGS 6, LLC   |  MONTERIS BC HOLDINGS 7, LLC
MATHEW 
W 
STROBECK 
DIRECTOR
ACCELERATE DIAGNOSTICS, INC
MATTHEW 
 
STROBECK 
DIRECTOR
COLLEGIUM PHARMACEUTICAL INC   |  PRECISION DERMATOLOGY, INC.   |  BIODESIX INC   |  ACCELR8 TECHNOLOGY CORP   |  BIRCHVIEW FUND LLC   |  METABOLIX, INC.   |  ED BC HOLDINGS, LLC   |  MONTERIS MEDICAL US, INC.   |  MONTERIS BC HOLDINGS 2, LLC   |  MONTERIS BC HOLDINGS 3, LLC
MATTHEW 
W. 
STROBECK 
DIRECTOR
ACCELERATE DIAGNOSTICS, INC
MATTHEW 
W. 
STROBECK, PH.D 
DIRECTOR
ACCELERATE DIAGNOSTICS, INC
FRANK 
J.M. 
TEN BRINK 
DIRECTOR
ACCELERATE DIAGNOSTICS, INC
CHARLES 
 
WATTS 
DIRECTOR
BIODESIX INC   |  ACCELERATE DIAGNOSTICS, INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-04-07
D
Link
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
$5,000,001 - $25,000,000 
Equity 
2022-03-24 
2021-09-29
D/A
Link
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
$5,000,001 - $25,000,000 
Equity 
2020-12-24 
2021-09-29
D
Link
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
$5,000,001 - $25,000,000 
Equity 
2021-09-22 
2021-03-01
D
Link
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
$5,000,001 - $25,000,000 
Equity 
2020-12-24 
2019-08-28
D
Link
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
DECLINE TO DISCLOSE 
Equity 
2019-08-20 
2014-06-04
D
Link
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
DECLINE TO DISCLOSE 
Equity 
2014-05-19 
2013-08-26
D
Link
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
$1 - $1,000,000 
Equity 
2013-08-14 
2012-07-17
D
Link
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
$1,000,001 - $5,000,000 
Equity 
2012-06-26 
2010-03-23
D
Link
OTHER HEALTH CARE 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
$1 - $1,000,000 
Equity 
2010-03-17 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
JANCO PARTNERS
4055
BRAD A. PAROBEK
NONE